计算生物学市场－全球产业规模、份额、趋势、机会和预测，按应用、工具、服务、最终用户、地区和竞争格局划分，2021-2031年预测

全球计算生物学市场规模将从2025年的57.4亿美元成长到2031年的91.3亿美元，复合年增长率为8.04%。计算生物学是一个关键领域，它利用演算法、数学模型和统计技术来分析和解释复杂的生物资料。

主要市场驱动因素

人工智慧和机器学习的融合正在从根本上重塑全球计算生物学市场，加速识别可行的候选疗法。先进的演算法和生成模型如今能够以前所未有的速度预测蛋白质结构并优化分子设计，从而显着减少临床前研究所需的时间和资金。

主要市场挑战

资料隐私和安全问题是全球计算生物学市场扩张的一大障碍。该领域从根本上依赖对包含敏感基因组和临床资讯的大量资料集进行聚合和分析，因此患者隐私至关重要。

主要市场趋势

数位孪生技术在电脑模拟临床试验中的应用，透过创建虚拟患者模型来模拟生物反应，正在革新药物研发的验证阶段。这种方法解决了传统随机对照试验效率低下的难题，它允许研究人员产生合成对照组，从而减少了安慰剂组所需的大量人体受试者招募工作。

目录

第一章：产品概述

第二章：研究方法

第三章：执行概要

第四章：顾客之声

第五章：全球计算生物学市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按应用领域（细胞和生物模拟、药物发现和疾病建模、临床前药物开发、临床试验、人体模拟软体）
  • 依工具分类（资料库、基础设施（硬体）、分析软体和服务）
  • 依服务类型（内部服务、合约服务）
  • 按最终用户（学术界、工业界和商业界）划分
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章：北美计算生物学市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲计算生物学市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区计算生物学市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲计算生物学市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿联酋
  • 南非

第十章：南美洲计算生物学市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章：市场动态

• 司机
• 挑战

第十二章：市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章：全球计算生物学市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商议价能力
• 顾客的力量
• 替代产品的威胁

第十五章：竞争格局

• Dassault Systemes SE
• Certara Inc
• Chemical Computing Group ULC
• Compugen Ltd
• Rosa & Co. LLC
• GeneData AG
• Insilico Biotechnology AG
• Instem PLC
• Strand Life Sciences Pvt Ltd
• Schrodinger Inc

第十六章：策略建议

第17章调查会社について・免责事项

The Global Computational Biology Market will grow from USD 5.74 Billion in 2025 to USD 9.13 Billion by 2031 at a 8.04% CAGR. Computational biology serves as a pivotal field that utilizes algorithms, mathematical models, and statistical techniques to analyze and interpret complex biological data.

Key Market Drivers

Integration of Artificial Intelligence and Machine Learning is fundamentally reshaping the Global Computational Biology Market by expediting the identification of viable therapeutic candidates. Advanced algorithms and generative models can now predict protein structures and optimize molecular designs with unprecedented speed, significantly reducing the time and capital required for preclinical research. This transformative potential has triggered substantial industrial consolidation and capital flow into AI-driven biotech firms.

Key Market Challenges

Data privacy and security concerns constitute a formidable barrier to the expansion of the global computational biology market. This field relies fundamentally on the aggregation and analysis of massive datasets containing sensitive genomic and clinical information, making patient confidentiality paramount. The risk of unauthorized access compels research institutions and pharmaceutical companies to implement restrictive data governance policies. These rigid protocols often result in data silos where valuable biological information remains isolated within a single organization rather than being shared across collaborative research networks.

Key Market Trends

Adoption of Digital Twins for In Silico Clinical Trials is revolutionizing the validation phase of pharmaceutical development by creating virtual patient models to simulate biological responses. This approach addresses the inefficiency of traditional randomized control trials by allowing researchers to generate synthetic control arms, thereby reducing the need for recruiting large numbers of human participants for placebo groups.

Key Market Players

• Dassault Systemes SE
• Certara Inc
• Chemical Computing Group ULC
• Compugen Ltd
• Rosa & Co. LLC
• GeneData AG
• Insilico Biotechnology AG
• Instem PLC
• Strand Life Sciences Pvt Ltd
• Schrodinger Inc

Report Scope:

In this report, the Global Computational Biology Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Computational Biology Market, By Application:

• Cellular and Biological Simulation
• Drug Discovery and Disease Modelling
• Preclinical Drug Development
• Clinical Trials
• Human Body Simulation Software

Computational Biology Market, By Tool:

• Databases
• Infrastructure (Hardware)
• Analysis Software and Services

Computational Biology Market, By Service:

• In-house
• Contract

Computational Biology Market, By End User:

• Academics
• Industry and Commercials

Computational Biology Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Computational Biology Market.

Available Customizations:

Global Computational Biology Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Computational Biology Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Application (Cellular and Biological Simulation, Drug Discovery and Disease Modelling, Preclinical Drug Development, Clinical Trials, Human Body Simulation Software)
  • 5.2.2. By Tool (Databases, Infrastructure (Hardware), Analysis Software and Services)
  • 5.2.3. By Service (In-house, Contract)
  • 5.2.4. By End User (Academics, Industry and Commercials)
  • 5.2.5. By Region
  • 5.2.6. By Company (2025)
• 5.3. Market Map

6. North America Computational Biology Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Application
  • 6.2.2. By Tool
  • 6.2.3. By Service
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Computational Biology Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Application
      • 6.3.1.2.2. By Tool
      • 6.3.1.2.3. By Service
      • 6.3.1.2.4. By End User
  • 6.3.2. Canada Computational Biology Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Application
      • 6.3.2.2.2. By Tool
      • 6.3.2.2.3. By Service
      • 6.3.2.2.4. By End User
  • 6.3.3. Mexico Computational Biology Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Application
      • 6.3.3.2.2. By Tool
      • 6.3.3.2.3. By Service
      • 6.3.3.2.4. By End User

7. Europe Computational Biology Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Application
  • 7.2.2. By Tool
  • 7.2.3. By Service
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Computational Biology Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Application
      • 7.3.1.2.2. By Tool
      • 7.3.1.2.3. By Service
      • 7.3.1.2.4. By End User
  • 7.3.2. France Computational Biology Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Application
      • 7.3.2.2.2. By Tool
      • 7.3.2.2.3. By Service
      • 7.3.2.2.4. By End User
  • 7.3.3. United Kingdom Computational Biology Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Application
      • 7.3.3.2.2. By Tool
      • 7.3.3.2.3. By Service
      • 7.3.3.2.4. By End User
  • 7.3.4. Italy Computational Biology Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Application
      • 7.3.4.2.2. By Tool
      • 7.3.4.2.3. By Service
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain Computational Biology Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Application
      • 7.3.5.2.2. By Tool
      • 7.3.5.2.3. By Service
      • 7.3.5.2.4. By End User

8. Asia Pacific Computational Biology Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Application
  • 8.2.2. By Tool
  • 8.2.3. By Service
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Computational Biology Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Application
      • 8.3.1.2.2. By Tool
      • 8.3.1.2.3. By Service
      • 8.3.1.2.4. By End User
  • 8.3.2. India Computational Biology Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Application
      • 8.3.2.2.2. By Tool
      • 8.3.2.2.3. By Service
      • 8.3.2.2.4. By End User
  • 8.3.3. Japan Computational Biology Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Application
      • 8.3.3.2.2. By Tool
      • 8.3.3.2.3. By Service
      • 8.3.3.2.4. By End User
  • 8.3.4. South Korea Computational Biology Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Application
      • 8.3.4.2.2. By Tool
      • 8.3.4.2.3. By Service
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia Computational Biology Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Application
      • 8.3.5.2.2. By Tool
      • 8.3.5.2.3. By Service
      • 8.3.5.2.4. By End User

9. Middle East & Africa Computational Biology Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Application
  • 9.2.2. By Tool
  • 9.2.3. By Service
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Computational Biology Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Application
      • 9.3.1.2.2. By Tool
      • 9.3.1.2.3. By Service
      • 9.3.1.2.4. By End User
  • 9.3.2. UAE Computational Biology Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Application
      • 9.3.2.2.2. By Tool
      • 9.3.2.2.3. By Service
      • 9.3.2.2.4. By End User
  • 9.3.3. South Africa Computational Biology Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Application
      • 9.3.3.2.2. By Tool
      • 9.3.3.2.3. By Service
      • 9.3.3.2.4. By End User

10. South America Computational Biology Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Application
  • 10.2.2. By Tool
  • 10.2.3. By Service
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Computational Biology Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Application
      • 10.3.1.2.2. By Tool
      • 10.3.1.2.3. By Service
      • 10.3.1.2.4. By End User
  • 10.3.2. Colombia Computational Biology Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Application
      • 10.3.2.2.2. By Tool
      • 10.3.2.2.3. By Service
      • 10.3.2.2.4. By End User
  • 10.3.3. Argentina Computational Biology Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Application
      • 10.3.3.2.2. By Tool
      • 10.3.3.2.3. By Service
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Computational Biology Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Dassault Systemes SE
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Certara Inc
• 15.3. Chemical Computing Group ULC
• 15.4. Compugen Ltd
• 15.5. Rosa & Co. LLC
• 15.6. GeneData AG
• 15.7. Insilico Biotechnology AG
• 15.8. Instem PLC
• 15.9. Strand Life Sciences Pvt Ltd
• 15.10. Schrodinger Inc

16. Strategic Recommendations

17. About Us & Disclaimer